KCNQ4: Difference between revisions

Jump to navigation Jump to search
m (Bot: HTTP→HTTPS)
imported>JCW-CleanerBot
m (→‎Further reading: task, replaced: Pflugers Arch → Pflügers Arch using AWB)
 
Line 8: Line 8:
== Clinical significance ==
== Clinical significance ==


The current generated by this channel is inhibited by [[muscarinic acetylcholine receptor M1]] and activated by retigabine, a novel anti-convulsant drug. Defects in this gene are a cause of [[sensorineural hearing loss|nonsyndromic sensorineural deafness]] type 2 (DFNA2), an autosomal dominant form of progressive hearing loss. Two transcript variants encoding different isoforms have been found for this gene.<ref name="entrez" />
The current generated by this channel is inhibited by [[muscarinic acetylcholine receptor M1]] and activated by [[retigabine]], a novel anti-convulsant drug. Defects in this gene are a cause of [[sensorineural hearing loss|nonsyndromic sensorineural deafness]] type 2 (DFNA2), an autosomal dominant form of progressive hearing loss. Two transcript variants encoding different isoforms have been found for this gene.<ref name="entrez" />


== Ligands ==
== Ligands ==
Line 32: Line 32:
*{{cite journal  |vauthors=Schwake M, Jentsch TJ, Friedrich T |title=A carboxy-terminal domain determines the subunit specificity of KCNQ K+ channel assembly |journal=EMBO Rep. |volume=4 |issue= 1 |pages= 76–81 |year= 2003 |pmid= 12524525 |doi= 10.1038/sj.embor.embor715  | pmc=1315815 }}
*{{cite journal  |vauthors=Schwake M, Jentsch TJ, Friedrich T |title=A carboxy-terminal domain determines the subunit specificity of KCNQ K+ channel assembly |journal=EMBO Rep. |volume=4 |issue= 1 |pages= 76–81 |year= 2003 |pmid= 12524525 |doi= 10.1038/sj.embor.embor715  | pmc=1315815 }}
*{{cite journal  |vauthors=Li Y, Langlais P, Gamper N, etal |title=Dual phosphorylations underlie modulation of unitary KCNQ K(+) channels by Src tyrosine kinase |journal=J. Biol. Chem. |volume=279 |issue= 44 |pages= 45399–407 |year= 2004 |pmid= 15304482 |doi= 10.1074/jbc.M408410200 }}
*{{cite journal  |vauthors=Li Y, Langlais P, Gamper N, etal |title=Dual phosphorylations underlie modulation of unitary KCNQ K(+) channels by Src tyrosine kinase |journal=J. Biol. Chem. |volume=279 |issue= 44 |pages= 45399–407 |year= 2004 |pmid= 15304482 |doi= 10.1074/jbc.M408410200 }}
*{{cite journal  |vauthors=Chambard JM, Ashmore JF |title=Regulation of the voltage-gated potassium channel KCNQ4 in the auditory pathway |journal=Pflugers Arch. |volume=450 |issue= 1 |pages= 34–44 |year= 2005 |pmid= 15660259 |doi= 10.1007/s00424-004-1366-2 }}
*{{cite journal  |vauthors=Chambard JM, Ashmore JF |title=Regulation of the voltage-gated potassium channel KCNQ4 in the auditory pathway |journal=Pflügers Arch. |volume=450 |issue= 1 |pages= 34–44 |year= 2005 |pmid= 15660259 |doi= 10.1007/s00424-004-1366-2 }}
*{{cite journal  |vauthors=Van Laer L, Carlsson PI, Ottschytsch N, etal |title=The contribution of genes involved in potassium-recycling in the inner ear to noise-induced hearing loss |journal=Hum. Mutat. |volume=27 |issue= 8 |pages= 786–95 |year= 2006 |pmid= 16823764 |doi= 10.1002/humu.20360 }}
*{{cite journal  |vauthors=Van Laer L, Carlsson PI, Ottschytsch N, etal |title=The contribution of genes involved in potassium-recycling in the inner ear to noise-induced hearing loss |journal=Hum. Mutat. |volume=27 |issue= 8 |pages= 786–95 |year= 2006 |pmid= 16823764 |doi= 10.1002/humu.20360 }}
*{{cite journal  |vauthors=Van Eyken E, Van Laer L, Fransen E, etal |title=KCNQ4: a gene for age-related hearing impairment? |journal=Hum. Mutat. |volume=27 |issue= 10 |pages= 1007–16 |year= 2006 |pmid= 16917933 |doi= 10.1002/humu.20375 }}
*{{cite journal  |vauthors=Van Eyken E, Van Laer L, Fransen E, etal |title=KCNQ4: a gene for age-related hearing impairment? |journal=Hum. Mutat. |volume=27 |issue= 10 |pages= 1007–16 |year= 2006 |pmid= 16917933 |doi= 10.1002/humu.20375 }}

Latest revision as of 16:04, 29 June 2018

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

Potassium voltage-gated channel subfamily KQT member 4 also known as voltage-gated potassium channel subunit Kv7.4 is a protein that in humans is encoded by the KCNQ4 gene.[1][2][3]

Function

The protein encoded by this gene forms a potassium channel that is thought to play a critical role in the regulation of neuronal excitability, particularly in sensory cells of the cochlea. The encoded protein can form a homomultimeric potassium channel or possibly a heteromultimeric channel in association with the protein encoded by the KCNQ3 gene.[3]

Clinical significance

The current generated by this channel is inhibited by muscarinic acetylcholine receptor M1 and activated by retigabine, a novel anti-convulsant drug. Defects in this gene are a cause of nonsyndromic sensorineural deafness type 2 (DFNA2), an autosomal dominant form of progressive hearing loss. Two transcript variants encoding different isoforms have been found for this gene.[3]

Ligands

  • ML213: KCNQ2/Q4 channel opener.[4]

See also

References

  1. Kubisch C, Schroeder BC, Friedrich T, Lutjohann B, El-Amraoui A, Marlin S, Petit C, Jentsch TJ (Mar 1999). "KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness". Cell. 96 (3): 437–46. doi:10.1016/S0092-8674(00)80556-5. PMID 10025409.
  2. Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, Robertson GA, Rudy B, Sanguinetti MC, Stuhmer W, Wang X (Dec 2005). "International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels". Pharmacol Rev. 57 (4): 473–508. doi:10.1124/pr.57.4.10. PMID 16382104.
  3. 3.0 3.1 3.2 "Entrez Gene: KCNQ4 potassium voltage-gated channel, KQT-like subfamily, member 4".
  4. Yu H, Wu M, Townsend SD, et al. (2011). "Discovery, Synthesis, and Structure Activity Relationship of a Series of N-Aryl- bicyclo[2.2.1]heptane-2-carboxamides: Characterization of ML213 as a Novel KCNQ2 and KCNQ4 Potassium Channel Opener". ACS Chem Neurosci. 2 (10): 572–577. doi:10.1021/cn200065b. PMC 3223964. PMID 22125664.

Further reading

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.